Phase separation of low-complexity domains in cellular function and disease

참고문헌 (127)

1. van der Lee, R., "Classification of intrinsically disordered regions and proteins", Chem. Rev, 114, pp.6589~6631 (2014)
2. Marcotte, E. M., "A census of protein repeats", J. Mol. Biol, 293, pp.151~160 (1999)
3. Golding, G. B., "Simple sequence is abundant in eukaryotic proteins", Protein Sci, 8, pp.1358~1361 (1999)
4. Alba, M. M., "Comparative analysis of amino acid repeats in rodents and humans", Genome Res, 14, pp.549~554 (2004)
5. Karlin, S., "Amino acid runs in eukaryotic proteomes and disease associations", Proc. Natl Acad. Sci. USA, 99, pp.333~338 (2002)
6. Kato, M., "A solid-state conceptualization of information transfer from gene to message to protein", Annu. Rev. Biochem, 87, pp.351~390 (2018)
7. King, O. D., "The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease", Brain Res, 1462, pp.61~80 (2012)
8. Courchaine, E. M., "Droplet organelles?", EMBO J, 35, pp.1603~1612 (2016)
9. Boeynaems, S., "Protein phase separation: a new phase in cell biology", Trends Cell Biol, 28, pp.420~435 (2018)
10. Kato, M., "How do protein domains of low sequence complexity work?", RNA, 28, pp.3~15 (2022)
11. Frey, S., "A saturated FG-repeat hydrogel can reproduce the permeability properties of nuclear pore complexes", Cell, 130, pp.512~523 (2007)
12. Frey, S., "FG-rich repeats of nuclear pore proteins form a three-dimensional meshwork with hydrogel-like properties", Science, 314, pp.815~817 (2006)
13. Lin, Y., "Toxic PR poly-dipeptides encoded by the C9orf72 repeat expansion target LC domain polymers", Cell, 167, pp.789~802.e712 (2016)
14. Zhou, X., "Transiently structured head domains control intermediate filament assembly", Proc. Natl Acad. Sci. USA, 118, pp.e2022121118~ (2021)
15. Brangwynne, C. P., "Germline P granules are liquid droplets that localize by controlled dissolution", condensation, 2009, pp.324, 1729~1732
16. Kato, M., "Cell-free formation of RNA granules : low complexity sequence domains form dynamic fibers within hydrogels", Cell, 149, pp.753~767 (2012)
17. Liu, X., "Phase separation drives decision making in cell division", J. Biol. Chem, 295, pp.13419~13431 (2020)
18. Harami, G. M., "Phase separation by ssDNA binding protein controlled via protein-protein and protein-DNA interactions", Proc. Natl Acad. Sci. USA, 117, pp.26206~26217 (2020)
19. Su, Q., "Liquid-liquid phase separation: orchestrating cell signaling through time and space", Mol. Cell, 81, pp.4137~4146 (2021)
20. Taniue, K., "Aberrant phase separation and cancer", FEBS J, 289, pp.17~39 (2022)
21. Kwon, I., "Phosphorylation-regulated binding of RNA polymerase II to fibrous polymers of low-complexity domains", Cell, 155, pp.1049~1060 (2013)
22. Nedelsky, N. B., "Pathological phase transitions in ALS-FTD impair dynamic RNA-protein granules", RNA, 28, pp.97~113 (2022)
23. Kwon, I., "Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells", Science, 345, pp.1139~1145 (2014)
24. Kim, G. H., "Distinct roles of hnRNPH1 low-complexity domains in splicing and transcription", Proc. Natl Acad. Sci. USA, 118, pp.e2109668118~ (2021)
25. Kim, E., "Phase transition of fibrillarin LC domain regulates localization and protein interaction of fibrillarin", Biochem. J, 478, pp.799~810 (2021)
26. Kato, M., "Cross-beta polymerization and hydrogel formation by low-complexity sequence proteins", Methods, 126, pp.3~11 (2017)
27. Kato, M., "Redox state controls phase separation of the yeast Ataxin-2protein via reversible oxidation of its methionine-rich low-complexity domain", Cell, 177, pp.711~721.e718 (2019)
28. Xiang, S., "The LC domain of hnRNPA2 adopts similar conformations in hydrogel polymers, liquid-like droplets, and nuclei", Cell, 163, pp.829~839 (2015)
29. Elbaum-Garfinkle, S., "The disordered P granule protein LAF-1 drives phase separation into droplets with tunable viscosity and dynamics", Proc. Natl Acad. Sci. USA, 112, pp.7189~7194 (2015)
30. Harrison, A. F., "RNA-binding proteins with prion-like domains in health and disease", Biochem. J, 474, pp.1417~1438 (2017)
31. Dignon, G. L., "Biomolecular phase separation: from molecular driving forces to macroscopic properties", Annu. Rev. Phys. Chem, 71, pp.53~75 (2020)
32. Khoury, G. A., "Proteome-wide post-translational modification statistics : frequency analysis and curation of the swiss-prot database", Sci. Rep, 1, pp.90~ (2011)
33. Murray, D. T., "Structure of FUS protein fibrils and its relevance to selfassembly and phase separation of low-complexity domains", Cell, 171, pp.615~627.e616 (2017)
34. Snider, N. T., "Post-translational modifications of intermediate filament proteins : mechanisms and functions", Nat. Rev. Mol. Cell Biol, 15, pp.163~177 (2014)
35. Geisler, N., "Phosphorylation of desmin in vitro inhibits formation of intermediate filaments; identification of three kinase A sites in the aminoterminal head domain", EMBO J, 7, pp.15~20 (1988)
36. Zhou, L. T., "A novel role of fragile X mental retardation protein in pre-mRNA alternative splicing through RNA-binding protein 14", Neuroscience, 349, pp.64~75 (2017)
37. Darnell, J. C., "The translation of translational control by FMRP: therapeutic targets for FXS", Nat. Neurosci, 16, pp.1530~1536 (2013)
38. Kao, D. I., "Altered mRNA transport, docking, and protein translation in neurons lacking fragile X mental retardation protein", Proc. Natl Acad. Sci. USA, 107, pp.15601~15606 (2010)
39. Ferron, L., "Fragile X mental retardation protein controls ion channel expression and activity", J. Physiol, 594, pp.5861~5867 (2016)
40. Tsang, B., "Phosphoregulated FMRP phase separation models activitydependent translation through bidirectional control of mRNA granule formation", Proc. Natl Acad. Sci. USA, 116, pp.4218~4227 (2019)
41. Ambadipudi, S., "Liquidliquid phase separation of the microtubule-binding repeats of the Alzheimerrelated protein Tau", Nat. Commun, 8, pp.275~ (2017)
42. Wegmann, S., "Tau protein liquid-liquid phase separation can initiate tau aggregation", EMBO J, 37, pp.e98049~ (2018)
43. Kato, M., "Redox-mediated regulation of low complexity domain self-association", Curr. Opin. Genet. Dev, 67, pp.111~118 (2021)
44. Lin, Y., "Redox-mediated regulation of an evolutionarily conserved crossbeta structure formed by the TDP43 low complexity domain", Proc. Natl Acad. Sci. USA, 117, pp.28727~28734 (2020)
45. Hofweber, M., "Phase separation of FUS is suppressed by its nuclear import receptor and arginine methylation", Cell, 173, pp.706~719.e713 (2018)
46. Qamar, S., "FUS phase separation is modulated by a molecular chaperone and methylation of arginine cation-pi interactions", Cell, 173, pp.720~734.e715 (2018)
47. Yasuda, S., "Stress-and ubiquitylation-dependent phase separation of the proteasome", Nature, 578, pp.296~300 (2020)
48. Bock, A. S., "N-terminal acetylation modestly enhances phase separation and reduces aggregation of the low-complexity domain of RNA-binding protein fused in sarcoma", Protein Sci, 30, pp.1337~1349 (2021)
49. Ukmar-Godec, T., "Lysine", RNA-interactions drive and regulate biomolecular condensation, 2019, pp.10, 2909~
50. Saito, M., "Acetylation of intrinsically disordered regions regulates phase separation", Nat. Chem. Biol, 15, pp.51~61 (2019)
51. McGurk, L., "Poly(ADP-Ribose) prevents pathological phase separation of TDP-43 by promoting liquid demixing and stress granule localization", Mol. Cell, 71, pp.703~717.e709 (2018)
52. Dao, T. P., "Ubiquitin modulates liquid–liquid phase separation of UBQLN2via disruption of multivalent interactions", Mol. Cell, 69, pp.965~978.e966 (2018)
53. Neupert, W., "A perspective on transport of proteins into mitochondria: a myriad of open questions", J. Mol. Biol, 427, pp.1135~1158 (2015)
54. Grossman, E., "Functional architecture of the nuclear pore complex", Annu. Rev. Biophys, 41, pp.557~584 (2012)
55. Mao, Y. S., "Biogenesis and function of nuclear bodies", Trends Genet, 27, pp.295~306 (2011)
56. Bond, C. S., "Paraspeckles : nuclear bodies built on long noncoding RNA", J. Cell Biol, 186, pp.637~644 (2009)
57. Anderson, P., "Stress granules : the Tao of RNA triage", Trends Biochem. Sci, 33, pp.141~150 (2008)
58. Lin, Y., "Formation and maturation of phase-separated liquid droplets by RNA-binding proteins", Mol. Cell, 60, pp.208~219 (2015)
59. Molliex, A., "Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization", Cell, 163, pp.123~133 (2015)
60. Patel, A., "A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation", Cell, 162, pp.1066~1077 (2015)
61. Murakami, T., "ALS", FTD mutation-induced phase transition of FUS liquid droplets and reversible hydrogels into irreversible hydrogels impairs RNP granule Function, 2015, pp.88, 678~690
62. Conicella, A. E., "ALS mutations disrupt phase separation mediated by alpha-helical structure in the TDP-43 low-complexity C-terminal domain", Structure, 24, pp.1537~1549 (2016)
63. Mackenzie, I. R., "TIA1 mutations in amyotrophic lateral sclerosis and frontotemporal dementia promote phase separation and alter stress granule dynamics", Neuron, 95, pp.808~816.e809 (2017)
64. Feric, M., "Coexisting liquid phases underlie nucleolar subcompartments", Cell, 165, pp.1686~1697 (2016)
65. White, M. R., "C9orf72 Poly(PR) dipeptide repeats disturb biomolecular phase separation and disrupt nucleolar function", Mol. Cell, 74, pp.713~728.e716 (2019)
66. Fatica, A., "Making ribosomes", Curr. Opin. Cell Biol, 14, pp.313~318 (2002)
67. Vieira, N. M., "A defect in the RNA-processing protein HNRPDL causes limbgirdle muscular dystrophy 1G(LGMD1G)", Hum. Mol. Genet, 23, pp.4103~4110 (2014)
68. Kim, H. J., "Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1cause multisystem proteinopathy and ALS", Nature, 495, pp.467~473 (2013)
69. Andersson, M. K., "The multifunctional FUS, EWS and TAF15 protooncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response", BMC Cell Biol, 9, pp.37~ (2008)
70. Zinszner, H., "A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP", Genes Dev, 8, pp.2513~2526 (1994)
71. Rabbitts, T. H., "Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16)in malignant liposarcoma", Nat. Genet, 4, pp.175~180 (1993)
72. Ichikawa, H., "Dual transforming activities of the FUS(TLS)-ERG leukemia fusion protein conferred by two N-terminal domains of FUS(TLS)", Mol. Cell. Biol, 19, pp.7639~7650 (1999)
73. Crozat, A., "Fusion of CHOP to a novel RNAbinding protein in human myxoid liposarcoma", Nature, 363, pp.640~644 (1993)
74. Bertolotti, A., "The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties", Oncogene, 18, pp.8000~8010 (1999)
75. Corden, J. L., "A unique structure at the carboxyl terminus of the largest subunit of eukaryotic RNA polymerase II", Proc. Natl Acad. Sci. USA, 82, pp.7934~7938 (1985)
76. Lee, J. M., "A protein kinase that phosphorylates the C-terminal repeat domain of the largest subunit of RNA polymerase II", Proc. Natl Acad. Sci. USA, 86, pp.3624~3628 (1989)
77. Guo, Y. E., "Pol II phosphorylation regulates a switch between transcriptional and splicing condensates", Nature, 572, pp.543~548 (2019)
78. Peng, L., "From start to end: phase separation and transcriptional regulation", Biochim. Biophys. Acta Gene Regul. Mech, 1863, pp.194641~ (2020)
79. Gueroussov, S., "Regulatory expansion in mammals of multivalent hnRNP assemblies that globally control alternative splicing", Cell, 170, pp.324~339.e323 (2017)
80. Chaudhury, A., "Heterogeneous nuclear ribonucleoproteins(hnRNPs)in cellular processes : focus on hnRNP E1’s multifunctional regulatory roles", RNA, 16, pp.1449~1462 (2010)
81. Kovar, H., "Dr. Jekyll and Mr. Hyde: the two faces of the FUS", EWS, Sarcoma, pp.2011, 2011[DOI]
82. Liu, W., "Roles of Cx43 and AKAP95 in ovarian cancer tissues in G1", S phase, 2015, pp.8, 14315~14324
83. Li, W., "Biophysical properties of AKAP95 protein condensates regulate splicing and tumorigenesis", Nat. Cell Biol, 22, pp.960~972 (2020)
84. Mattson, M. P., "Ageing and neuronal vulnerability", Nat. Rev. Neurosci, 7, pp.278~294 (2006)
85. Uversky, V. N., "Intrinsic disorder in proteins associated with neurodegenerative diseases", Front. Biosci, 14, pp.5188~5238 (2009)
86. Zbinden, A., "Phase separation and neurodegenerative diseases : a disturbance in the force", Dev. Cell, 55, pp.45~68 (2020)
87. Brown, R. H. Jr, "Amyotrophic lateral sclerosis", N. Engl. J. Med, 377, pp.1602~ (2017)
88. Sreedharan, J., "TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis", Science, 319, pp.1668~1672 (2008)
89. Kabashi, E., "TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis", Nat. Genet, 40, pp.572~574 (2008)
90. Kwiatkowski, T. J. Jr, "Mutations in the FUS", TLS gene on chromosome 16cause familial amyotrophic lateral sclerosis, 2009, pp.323, 1205~1208
91. Vance, C., "Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6", Science, 323, pp.1208~1211 (2009)
92. Liu, Q., "Whole-exome sequencing identifies a missense mutation in hnRNPA1 in a family with flail arm ALS", Neurology, 87, pp.1763~1769 (2016)
93. Johnson, J. O., "Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis", Nat. Neurosci, 17, pp.664~666 (2014)
94. Leoni, T. B., "A novel multisystem proteinopathy caused by a missense ANXA11 variant", Ann. Neurol, 90, pp.239~252 (2021)
95. Smith, B. N., "Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis", Sci. Transl. Med, 9, pp.eaad9157~ (2017)
96. Mathieu, C., "Beyond aggregation : Pathological phase transitions in neurodegenerative disease", Science, 370, pp.56~60 (2020)
97. DeJesus-Hernandez, M., "Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS", Neuron, 72, pp.245~256 (2011)
98. Renton, A. E., "A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD", Neuron, 72, pp.257~268 (2011)
99. Taylor, J. P., "Decoding ALS : from genes to mechanism", Nature, 539, pp.197~206 (2016)
100. Ash, P. E., "Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD", ALS, 2013, pp.77, 639~646
101. Balendra, R., "C9orf72-mediated ALS and FTD : multiple pathways to disease", Nat. Rev. Neurol, 14, pp.544~558 (2018)
102. Donnelly, C. J., "RNA toxicity from the ALS", FTD C9ORF72 expansion is mitigated by antisense intervention, 2013, pp.80, 415~428
103. Lagier-Tourenne, C., "Targeted degradation of sense and antisense C9orf72RNA foci as therapy for ALS and frontotemporal degeneration", Proc. Natl Acad. Sci. USA, 110, pp.E4530~E4539 (2013)
104. Mizielinska, S., "C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci", Acta Neuropathol, 126, pp.845~857 (2013)
105. Mori, K., "The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD", ALS, 2013, pp.339, 1335~1338
106. Zu, T., "RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia", Proc. Natl Acad. Sci. USA, 110, pp.E4968~E4977 (2013)
107. Manley, J. L., "SR proteins and splicing control", Genes Dev, 10, pp.1569~1579 (1996)
108. Roth, M. B., "A monoclonal antibody that recognizes a phosphorylated epitope stains lampbrush chromosome loops and small granules in the amphibian germinal vesicle", J. Cell Biol, 111, pp.2217~2223 (1990)
109. Colwill, K., "The Clk", Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution, 1996, pp.15, 265~275
110. Lin, C. L., "Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis", Neuron, 20, pp.589~602 (1998)
111. Jovicic, A., "Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD", ALS, 2015, pp.18, 1226~1229
112. Freibaum, B. D., "GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport", Nature, 525, pp.129~133 (2015)
113. Chen, C., "Phase separation and toxicity of C9orf72 poly(PR) depends on alternate distribution of arginine", J. Cell Biol, 220, pp.e202103160~ (2021)
114. Boeynaems, S., "Phase separation of C9orf72 dipeptide repeats perturbs stress granule dynamics", Mol. Cell, 65, pp.1044~1055.e1045 (2017)
115. Lee, K. H., "C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles", Cell, 167, pp.774~788.e717 (2016)
116. Zhang, Y. J., "Poly(GR)impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis", Nat. Med, 24, pp.1136~1142 (2018)
117. Shi, K. Y., "Toxic PRn poly-dipeptides encoded by the C9orf72 repeat expansion block nuclear import and export", Proc. Natl Acad. Sci. USA, 114, pp.E1111~E1117 (2017)
118. Wen, X., "Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS", FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death, 2014, pp.84, 1213~1225
119. Haeusler, A. R., "C9orf72 nucleotide repeat structures initiate molecular cascades of disease", Nature, 507, pp.195~200 (2014)
120. Selvaraj, B. T., "C9ORF72 repeat expansion causes vulnerability of motor neurons to Ca(2+)-permeable AMPA receptor-mediated excitotoxicity", Nat. Commun, 9, pp.347~ (2018)
121. Schanz, O., "Cortical hyperexcitability in patients with C9ORF72 mutations:relationship to phenotype", Muscle Nerve, 54, pp.264~269 (2016)
122. Perkins, E. M., "Altered network properties in C9ORF72 repeat expansion cortical neurons are due to synaptic dysfunction", Mol. Neurodegener, 16, pp.13~ (2021)
123. Jo, Y., "Poly-dipeptides produced from C9orf72 hexanucleotide repeats cause selective motor neuron hyperexcitability in ALS", Proc. Natl Acad. Sci. USA, 119, pp.e2113813119~ (2022)
124. Shaw, J. E., "Functional interactions of ion channels with the actin cytoskeleton : does coupling to dynamic actin regulate NMDA receptors?", J. Physiol, 599, pp.431~441 (2021)
125. Morachevskaya, E. A., "Actin dynamics as critical ion channel regulator: ENaC and Piezo in focus", Am. J. Physiol. Cell Physiol, 320, pp.C696~C702 (2021)
126. Curran, J., "Alternative paradigms for ion channelopathies : disorders of ion channel membrane trafficking and posttranslational modification", Annu. Rev. Physiol, 77, pp.505~524 (2015)
127. Steele, D. F., "Cytoskeletal roles in cardiac ion channel expression", Biochim. Biophys. Acta, 1838, pp.665~673 (2014)

관련 논문AI추천